patent/WO-0218353-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0218353-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate	2001-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41fa4088ca2bc755c2168e42ad5e6273 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0de8bc010ebb7f2817545ba082e937 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7558e4a0accecf1e6083da930d0ee931
publicationDate	2002-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-0218353-A3
titleOfInvention	Oxazolidinone chemotherapeutic agents
abstract	Compounds of the formula (I) or therapeutically acceptable salts or prodrugs thereof, are useful for treating bacterial infections, psoriasis, arthritis, and toxicity due to chemotherapy. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
priorityDate	2000-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4476136-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040306-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4705799-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6277868-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0184170-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2458547-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069

Total number of triples: 39.